Cite

    Sangana, R. et al. (2022). Therapeutic equivalence of vildagliptin 100 mg once daily modified release to 50 mg twice daily immediate release formulation: An open-label, randomized, two-period, single- and multiple-dose, 6-day crossover study. Diabetes & metabolic syndrome. 16 (3), p. . [Online].